Alliance Pharma plc Cash Flow Conversion Efficiency

Latest as of December 2024: 0.099x

Alliance Pharma plc cash flow conversion efficiency. Based on the latest financial reports, Alliance Pharma plc (APH) has a cash flow conversion efficiency ratio of 0.099x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX20.47 Million ≈ $2.49K USD) by net assets (GBX207.64 Million ≈ $25.26K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Alliance Pharma plc (1999–2024)

Cash flow conversion efficiency of Alliance Pharma plc from 1999 to 2024. This chart illustrates how Alliance Pharma plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View APH stock price for real-time trading data and today's change.

Alliance Pharma plc Cash Flow Conversion Ratio Explained

Alliance Pharma plc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Alliance Pharma plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alliance Pharma plc ranked by their cash flow conversion efficiency. Also see Alliance Pharma plc (APH) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Ambica Agarbathies & Aroma industries Limited NSE:AMBICAAGAR	0.071x
Modern Times Group Mtg AB ST:MTG-A	0.079x
Sego Resources Inc V:SGZ	-0.015x
Critical Minerals Group Ltd AU:CMG	0.171x
One SA WAR:FMG	0.074x
Karma Energy Limited NSE:KARMAENG	0.027x
Instituto Rosenbusch S.A. BA:ROSE	-1.542x
SINTEZA S.A. RO:STZ	N/A

Annual Cash Flow Conversion Efficiency for Alliance Pharma plc (1999–2024)

The table below shows the annual cash flow conversion efficiency of Alliance Pharma plc from 1999 to 2024. Review Alliance Pharma plc (APH) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX207.64 Million ≈ $25.26K	GBX38.72 Million ≈ $4.71K	0.186x	+29.33%
2023-12-31	GBX217.87 Million ≈ $26.51K	GBX31.41 Million ≈ $3.82K	0.144x	+97.75%
2022-12-31	GBX287.66 Million ≈ $35.00K	GBX20.97 Million ≈ $2.55K	0.073x	-46.73%
2021-12-31	GBX282.49 Million ≈ $34.37K	GBX38.66 Million ≈ $4.70K	0.137x	-7.50%
2020-12-31	GBX280.96 Million ≈ $34.18K	GBX41.57 Million ≈ $5.06K	0.148x	+13.44%
2019-12-31	GBX274.18 Million ≈ $33.36K	GBX35.76 Million ≈ $4.35K	0.130x	+48.36%
2018-12-31	GBX252.20 Million ≈ $30.69K	GBX22.17 Million ≈ $2.70K	0.088x	-32.75%
2017-12-31	GBX203.38 Million ≈ $24.75K	GBX26.58 Million ≈ $3.23K	0.131x	+38.44%
2016-12-31	GBX179.26 Million ≈ $21.81K	GBX16.93 Million ≈ $2.06K	0.094x	+92.29%
2015-12-31	GBX162.44 Million ≈ $19.76K	GBX7.98 Million ≈ $970.45	0.049x	-69.58%
2014-12-31	GBX70.78 Million ≈ $8.61K	GBX11.42 Million ≈ $1.39K	0.161x	+4.05%
2013-12-31	GBX64.67 Million ≈ $7.87K	GBX10.03 Million ≈ $1.22K	0.155x	-35.33%
2012-12-31	GBX51.85 Million ≈ $6.31K	GBX12.44 Million ≈ $1.51K	0.240x	+21.38%
2011-12-31	GBX44.13 Million ≈ $5.37K	GBX8.72 Million ≈ $1.06K	0.198x	-52.14%
2010-12-31	GBX36.08 Million ≈ $4.39K	GBX14.89 Million ≈ $1.81K	0.413x	-10.77%
2009-12-31	GBX16.63 Million ≈ $2.02K	GBX7.69 Million ≈ $936.14	0.463x	+55.02%
2008-12-31	GBX8.77 Million ≈ $1.07K	GBX2.62 Million ≈ $318.29	0.298x	+16.83%
2007-12-31	GBX6.67 Million ≈ $811.06	GBX1.70 Million ≈ $207.21	0.255x	+392.87%
2006-12-31	GBX10.43 Million ≈ $1.27K	GBX-910.00K ≈ $-110.72	-0.087x	-281.83%
2005-12-31	GBX7.50 Million ≈ $913.02	GBX360.00K ≈ $43.80	0.048x	+229.42%
2005-02-28	GBX6.83 Million ≈ $830.41	GBX-253.00K ≈ $-30.78	-0.037x	+93.01%
2004-02-29	GBX2.23 Million ≈ $270.72	GBX-1.18 Million ≈ $-143.57	-0.530x	+89.46%
2003-02-28	GBX-194.00K ≈ $-23.60	GBX976.00K ≈ $118.75	-5.031x	-13921.47%
2002-12-31	GBX2.24 Million ≈ $272.16	GBX-80.26K ≈ $-9.77	-0.036x	+97.21%
2002-02-28	GBX538.00K ≈ $65.46	GBX-692.00K ≈ $-84.20	-1.286x	-3926.58%
2001-02-28	GBX595.00K ≈ $72.39	GBX20.00K ≈ $2.43	0.034x	-95.49%
2000-02-29	GBX451.00K ≈ $54.87	GBX336.00K ≈ $40.88	0.745x	-93.85%
1999-02-28	GBX114.00K ≈ $13.87	GBX1.38 Million ≈ $168.03	12.114x	--

About Alliance Pharma plc

LSE:APH UK Drug Manufacturers - Specialty & Generic

Market Cap

$4.26 Million

GBX34.97 Billion GBX

Market Cap Rank

#28808 Global

#513 in UK

Share Price

GBX64.70

Change (1 day)

+0.00%

52-Week Range

GBX64.70 - GBX64.70

All Time High

GBX116.47